VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Information Disclosure
Information Disclosure
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Close Filter
Find report
Search
11/28/2024
IMP - BOD Decision on the appointment of the Nomination and Compensation Committee's Chairman
11/26/2024
IMP - Disclosure on the termination of Mephydica as an associate company
11/07/2024
IMP - Official letter to HOSE: Adjust the Voting Result Minutes of shareholders' written opinions No. 03/2024/BB-DHDCD-IMP dated October 30, 2024
10/30/2024
IMP - Announcement on the change in personnel of Imexpharm Corporation
10/30/2024
IMP - BOD Resolution No. 17 on dismissal/election of BOD Chairman
10/30/2024
IMP - Resolution of the GMS No. 04 approving the implementation of the Cat Khanh Pharmaceutical Factory Complex Project
10/30/2024
IMP - Resolution of the GMS No. 03 approving certain issues by collecting written opinions
10/30/2024
IMP - Minutes of voting checking results of shareholders' written opinions (2nd time in 2024)
10/18/2024
IMP - Financial Statements Q3. 2024
10/17/2024
IMP - Documents to collect GMS's opinions in writing (2nd time in 2024)
1
2
3
4
5
6
7
8
9
10
›
»